Optimising malignant melanoma management in Europe
EUMelaReg collects health information to improve care and treatment for patients with skin cancer
Sustaining and fostering collaboration between academia and industry
for the collection of baseline, treatment and outcome data of representative samples of malignant melanoma patients of major European countries.
Building the largest and quickest melanoma registry in the world
EUMelaReg collects real-world data on melanoma patients throughout Europe and integrates them in a data warehouse.

Quality approved data from more than 25,000 patients in EUMelaReg ­

We are proud to announce that after 7 years of intensive registry work, we have reached a significant milestone: Our European Melanoma Registry now includes quality approved data from more than 25,000 patients, including about 3,000 patients with non-melanoma skin cancer!

This achievement would not have been possible without the continuous support and co-operation of our 18 member countries. Many thanks to everyone who has contributed to this success.

We look forward to further progress in the coming years.